Schäfer W, Fischinger P J, Collins J J, Bolognesi D P
J Virol. 1977 Jan;21(1):35-40. doi: 10.1128/JVI.21.1.35-40.1977.
Purified gp71 of Friend murine leukemia virus (FLV) can interfere with virus infection, absorb neutralizing antibody, and in the presence of group-specific anti-gp71 antibody, hemagglutinate sheep erythrocytes. Interference by FLV gp71 with several murine leukemia viruses (MuLV) was tested in the XC and S + L- assay systems. Treatment of gp71 with trypsin or Pronase eliminated its interfering capacity. However, treatment with neuraminidase or a mixture of glycosidase enzymes, which left the major serological properties of gp71 intact, did not reduce the interference potential of gp71 for FLV or AKR MuLV. The capacity of gp71 to absorb type- or group-specific virus-neutralizing antibodies was similarly affected by the various enzyme treatments. In contrast, indirect hemagglutination by gp71 was abolished not only by proteases but also by treatment with glycosidase enzymes, although neuraminidase had no effect. Preliminary data indicate that infectivity of FLV or xenotropic MuLV was not affected by short treatment with glycosidase enzymes.
弗氏小鼠白血病病毒(FLV)纯化的gp71可干扰病毒感染、吸附中和抗体,并且在存在群特异性抗gp71抗体的情况下,能使绵羊红细胞发生血凝。在XC和S + L-检测系统中测试了FLV gp71对几种小鼠白血病病毒(MuLV)的干扰作用。用胰蛋白酶或链霉蛋白酶处理gp71可消除其干扰能力。然而,用神经氨酸酶或糖苷酶混合物处理,虽使gp71的主要血清学特性保持完整,但并未降低gp71对FLV或AKR MuLV的干扰潜力。gp71吸附型或群特异性病毒中和抗体的能力同样受到各种酶处理的影响。相比之下,gp71的间接血凝不仅被蛋白酶消除,也被糖苷酶处理消除,尽管神经氨酸酶没有作用。初步数据表明,糖苷酶短时间处理不会影响FLV或嗜异性MuLV的感染性。